155 related articles for article (PubMed ID: 23541442)
1. Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin.
Valente AJ; Yoshida T; Izadpanah R; Delafontaine P; Siebenlist U; Chandrasekar B
Cell Signal; 2013 Jun; 25(6):1447-56. PubMed ID: 23541442
[TBL] [Abstract][Full Text] [Related]
2. TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiation.
Valente AJ; Sakamuri SS; Siddesha JM; Yoshida T; Gardner JD; Prabhu R; Siebenlist U; Chandrasekar B
Cell Signal; 2013 Nov; 25(11):2176-84. PubMed ID: 23872479
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.
Valente AJ; Yoshida T; Murthy SN; Sakamuri SS; Katsuyama M; Clark RA; Delafontaine P; Chandrasekar B
Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H282-96. PubMed ID: 22636674
[TBL] [Abstract][Full Text] [Related]
4. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
[TBL] [Abstract][Full Text] [Related]
5. The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.
Sukhanov S; Higashi Y; Yoshida T; Mummidi S; Aroor AR; Jeffrey Russell J; Bender SB; DeMarco VG; Chandrasekar B
Cell Signal; 2021 Jan; 77():109825. PubMed ID: 33160017
[TBL] [Abstract][Full Text] [Related]
6. CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.
Venkatesan B; Valente AJ; Das NA; Carpenter AJ; Yoshida T; Delafontaine JL; Siebenlist U; Chandrasekar B
Cell Signal; 2013 Jan; 25(1):359-71. PubMed ID: 23085260
[TBL] [Abstract][Full Text] [Related]
7. RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation.
Mummidi S; Das NA; Carpenter AJ; Yoshida T; Yariswamy M; Mostany R; Izadpanah R; Higashi Y; Sukhanov S; Noda M; Siebenlist U; Rector RS; Chandrasekar B
J Cell Physiol; 2019 Dec; 234(12):22242-22259. PubMed ID: 31074012
[TBL] [Abstract][Full Text] [Related]
8. OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators.
Valente AJ; Irimpen AM; Siebenlist U; Chandrasekar B
Free Radic Biol Med; 2014 May; 70():117-28. PubMed ID: 24561578
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells.
Pozo M; de Nicolás R; Egido J; González-Cabrero J
Eur J Pharmacol; 2006 Oct; 548(1-3):53-63. PubMed ID: 16973154
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin.
Chandrasekar B; Mummidi S; Mahimainathan L; Patel DN; Bailey SR; Imam SZ; Greene WC; Valente AJ
J Biol Chem; 2006 Jun; 281(22):15099-109. PubMed ID: 16554298
[TBL] [Abstract][Full Text] [Related]
11. The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.
Somanna NK; Valente AJ; Krenz M; Fay WP; Delafontaine P; Chandrasekar B
J Cell Physiol; 2016 May; 231(5):1130-41. PubMed ID: 26445208
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.
Chen MC; Tsai YC; Tseng JH; Liou JJ; Horng S; Wen HC; Fan YC; Zhong WB; Hsu SP
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236027
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells.
Shyu KG; Chen SC; Wang BW; Cheng WP; Hung HF
Clin Sci (Lond); 2012 Jan; 122(1):33-42. PubMed ID: 21806545
[TBL] [Abstract][Full Text] [Related]
15. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin decreases IL-6 and IL-8 production in epithelial cells.
Sakoda K; Yamamoto M; Negishi Y; Liao JK; Node K; Izumi Y
J Dent Res; 2006 Jun; 85(6):520-3. PubMed ID: 16723648
[TBL] [Abstract][Full Text] [Related]
17. TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells.
Padilla J; Carpenter AJ; Das NA; Kandikattu HK; López-Ongil S; Martinez-Lemus LA; Siebenlist U; DeMarco VG; Chandrasekar B
Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H52-H64. PubMed ID: 28971844
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of simvastatin on the TNF-alpha- and angiotensin II-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ROS generation.
Park SY; Lee JS; Ko YJ; Kim AR; Choi MK; Kwak MK; Choi HG; Yong CS; Kim JA
Arch Pharm Res; 2008 Feb; 31(2):195-204. PubMed ID: 18365690
[TBL] [Abstract][Full Text] [Related]
19. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ
Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
